AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06727045 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mandala Coloring
Description: A literature review was conducted to determine the frequency and number of mandalas to be applied to the patients in the intervention group, and the average of the number of mandala sessions applied to different patient groups was obtained, and mandala application was performed during a total of eight hemodialysis sessions, every other day. Mandala painting was performed approximately 30 minutes after the start of HD treatment, considering the art therapist's recommendation and the symptoms that may develop during HD. Each mandala painting was performed with a structured and different mandala pattern. Since it was stated that the use of round patterns instead of square patterns was effective in increasing the comfort level, the booklet called Mandala Booklet, consisting of 8 structured mandala patterns with round shapes and containing general information about mandala, was used in the study. The group was informed about the content of the booklet face to face. Dry pencils were prefer
Study NCT05094297 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Investigate the effects of an exercise intervention on U.S. Veterans.
Description: Enrolled subjects will be asked to complete 94 total visits (4 study testing visits and 90 exercise visits). They will be tested for fitness, strength, and health risk factors at UIC 4 times and will complete 90 exercise training visits at the GH FITLab over the next 18 months.
Study NCT06593574 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Robotic laminectomy
Description: Surgical robots are used to assist with laminectomy
Study NCT06593574 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional laminectomy
Description: Instead of relying on a surgical robot, doctors perform the laminectomy themselves with an ultrasonic osteotome
Study NCT06651580 — intervention group
Intervention type: PROCEDURE
Intervention: Biospecimen Collection
Description: Undergo collection of blood, saliva, urine or stool samples
Study NCT05215951 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: osimertinib
Description: Dose Formulation: tablet； Dosage Level(s): osimertinib 80 mg QD for oral administration; Dosage formulation, dose reduction:40 mg QD for oral administration
Study NCT06651580 — intervention group
Intervention type: OTHER
Intervention: Quality-of-Life Assessment
Description: Complete QoL assessment
Study NCT06651580 — intervention group
Intervention type: OTHER
Intervention: Questionnaire Administration
Description: Complete questionnaire
Study NCT06651463 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Videorecording
Description: Two cameras will be used to make the recordings: a classic camera placed on a stand 1 meter from your head, outside the sterile area and the color camera of the microscope used for the surgery.
Study NCT05089591 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intense Pulsed Light therapy
Description: The LacryStim System is a CE marked device for treatment of meibomian gland dysfunction. It stimulates and reactivates meibomian glands and improves the related dry eye condition. Intense pulsed light is emitted with a light spectrum from 610nm to 1200nm. Each treatment consists of short individual pulses lasting for 4ms separated by a 26ms lasting interval to hinder tissue temperature increase, thermal damage to the skin and inflammatory reaction. During this phase 8 to 12 J / cm2 are delivered. Selection of total energy levels depends on the skin type (Fitzpatrick Skin Types) as recommended by the manufacturer.
Study NCT05089591 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Treatment
Description: The fellow eye serves as the control eye. Study eye receives the standard energy dose as recommended by the manufacturer (between 8 and 12J/cm2, in accordance with the manufacturer's recommendations). The control eye is treated using low energy dose energy (1J/ cm2) as sham treatment, ensuring blinding of the respective patient.
Study NCT06727071 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Hyperglycemic clamp
Description: A continuous infusion of 20% dextrose will be maintained throughout the procedure, while a variable rate of insulin infusion will be used to control participants blood glucose level.
Study NCT06725498 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab-jsgr
Description: 200mg, Q3W
Study NCT06725498 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: 60-75 mg/㎡, Q3W
Study NCT06725498 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albumin-Bound Paclitaxel
Description: 260 mg/㎡, Q3W
Study NCT06725498 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: Radical Radiotherapy or adjuvant Radiotherapy per guidelines.
Study NCT06726642 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cell-free DNA analysis
Description: Analysis of cell-free DNA in blood plasma will involve targeted sequencing of key cancer-related genes, cell-free methylated DNA immunoprecipitation and high-throughput sequencing (cfMeDIP-seq), and shallow whole genome sequencing (sWGS).
Study NCT06726629 — intervention group
Intervention type: OTHER
Intervention: Version Of The New Knee Society Knee Scoring System
Description: All patients will be subjected to the same clinical and radiographic checks, the data of which will be collected in the different centres
Study NCT05030168 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketosteril
Description: ketoanalogues of essential amino acid
Study NCT06507930 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telehealth Hospice Visits
Description: Telehealth check-in appointments with oncology care team, MD, PA, NP, or hospice nurse, via HIPAA compliant telehealth platform, Zoom, or by phone call.
Study NCT05350449 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Loving-kindness Meditation
Description: Loving-kindness meditation is a type of mindfulness practice where the focus is on love/compassion and kindness for self and others. The guided meditation will be provided via recording device. The intervention is 4 week long.
Study NCT05286502 — intervention group
Intervention type: DEVICE
Intervention: fundus photography
Description: color fundus photography
Study NCT05154253 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Biomotum Spark: Robotic ankle assistance
Description: A lightweight assistive wearable ankle robotic device.
Study NCT05154253 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Biomotum Spark: Robotic ankle resistance
Description: A lightweight resistive wearable ankle robotic device.
Study NCT05154253 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard gait training
Description: Standard gait training without a device.
Study NCT05154253 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ankle foot orthosis
Description: Standard ankle foot orthosis
Study NCT05154253 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard physical therapy
Description: Physical therapy without a device.
Study NCT05154253 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard walking
Description: Walking without a device
Study NCT05858372 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Chios Mastiha essential oil
Description: 1 soft gel capsule containing 200 mg of CMO and 100 mg of other excipients being medium chain triglycerides, while the shell was made of bovine gelatin and glycerol
Study NCT05858372 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05935332 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RPT193
Description: RPT193 is an antagonist of the C-C motif chemokine receptor 4 (CCR4) that inhibits CCR4-mediated chemotaxis toward both CCL22 and CCL17
Study NCT05935332 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo
Study NCT05590052 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bipolar Electrosurgery
Description: Achievement of hemostasis using bipolar electrosurgery
Study NCT05590052 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Thermocautery
Description: achievement of hemostasis using thermocautery
Study NCT06550219 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nasal humidified heated high flow cannula (NHHHC)
Description: Patients in this arm will receive humidified heated high flow using Vapotherm device, USA. Stating with 2 L/min flow and increase gradually till 8L/minute, guided by oxygen requirements.
Study NCT06550219 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nasal intermittent positive pressure ventilation (NIPPV)
Description: Patients in this arm will receive both PEEP (positive end expiratory pressure ) and PIP (peak inspiratory pressure) using SLE 5000/6000 device, UK . Pressures will be adjusted according to severity of respiratory distress.
Study NCT06550219 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nasal continuous positive airway pressure NCPAP
Description: Patients in this arm will receive PEEP (positive end expiratory pressure ), stating from 5 mbar to reach maximally 8 mbar.
Study NCT06550219 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: lung ultrasound
Description: Lung ultrasound (LUS) machine is a mobile device (Philips HDll XE, USA) with s8-3 probe with a frequency range of 8-3 MHz will be used as ultrasound machine. Throughout the period of non-invasive respiratory support Patient will be monitored by: LUS,Heart rate, Respiratory rate, Mean arterial pressure, Oxygen saturation index, Oxygen index, PaO2, blood gases and Fractional inspired oxygen (Fio2).
Study NCT05609513 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HTN-BASIC
Description: The HTN-BASIC intervention will consist of providing consistent access to diagnostic equipment and evidence-based antihypertensive drugs at no cost to the hypertensive patients. Access to a consistent supply of three anti-hypertensive drugs (amlodipine 5, 10mg; valsartan 80, 160mg; and hydrochlorothiazide 12.5, 25mg) will be supplied to each clinic in the trial.
Study NCT05609513 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HTN-PLUS
Description: In addition to receiving all the components of HTN-BASIC, HTN-PLUS sites will receive an enhanced, more human-resource intensive package of interventions that have been developed in consultation with key stakeholders during our human-centered design phase. The intervention components will include four broad categories- (1) hypertension training, (2) differentiated service delivery and (3) remote patient monitoring for hypertension and (4) Performance Improvement Program. Uptake of all components will be assessed on a monthly basis during the intervention period. These interventions will by nature cost more, and so cost data will be rigorously collected as well.
Study NCT06298721 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Personalized outcome prediction tool + targeted interventions
Description: * TKA Personalized Outcome Prediction Tool to aid in setting expectations~* Mental Health Screening/Intervention~* Physical Therapy Pre-surgery Assessments \& Rehabilitation
Study NCT06298721 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care TKA
Description: - Standard of care preoperative TKA clinic appointment to discuss plan for surgery and get consent
Study NCT04951752 — intervention group
Intervention type: DRUG
Intervention: Ropivacaine injection
Description: Transmuscular quadratus lumborum block - active
Study NCT05317065 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfullness Based Stress Reduction (MBSR) intervention
Description: Mindfullness Based Stress Reduction (MBSR) intervention: Monitoring stress and anxiety levels with mindfulness program
Study NCT06525779 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Use of macintosh laryngoscope
Description: The requirement of external laryngeal manipulation recorded in use of macintosh vs mcGrath laryngoscope in double lumen tube insertion
Study NCT06525779 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Use of mcGarth laryngoscope
Description: Use of mcGarth laryngoscope
Study NCT06328790 — intervention group
Intervention type: OTHER
Intervention: Multidisciplinary Rehabilitation Training
Description: 34 Patients will attend the in-person 5-day rehabilitation program (2 h/day) followed by a 12-weeks telemedicine program (1 h/week).
Study NCT06328790 — intervention group
Intervention type: BEHAVIORAL
Intervention: Cross-sectional study on patients with FMD and patients with structural/organic diseases
Description: Each subject will undergo behavioural, neurophysiological, and Magnetic Resonance Imaging (MRI) tests exploring the motor, exteroceptive and interoceptive domains.
Study NCT06328790 — intervention group
Intervention type: BEHAVIORAL
Intervention: Cross-sectional study on patients with FMD and healthy controls (HC)
Description: Each subject will undergo a set of behavioural, neurophysiological, and Magnetic Resonance Imaging (MRI) tests exploring the motor, exteroceptive and
Study NCT06167304 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Technology-implemented exercise therapy
Description: Therapy plans are performed at home overseen by a remote physical therapist via SimpleTherapy.
Study NCT06167304 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Physical Therapy
Description: Traditional physical therapy per Standard of care.
Study NCT06109064 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Unrelated Umbilical Cord Blood
Description: The requirements of unrelated umbilical cord blood: recipient-donor HLA match is 0-3/10, same blood type.
Study NCT05630352 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
Description: Injection in the muscle
Study NCT05630352 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 6 microgram dose
Description: Injection in the muscle
Study NCT05630352 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose
Description: Injection in the muscle
Study NCT05630352 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 1 microgram dose
Description: Injection in the muscle
Study NCT06381349 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Gastric Alimetry test
Description: Gastric Alimetry test will be performed within 30-days prior to G-POEM procedure. It's results will not inform clinical management in this observational study.
Study NCT04959526 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Shear-wave elastography
Description: Ultrasound based imaging of diaphragm muscle activity
Study NCT06109064 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Patients will be treated with Venetoclax (100 mg on day 1, 200 mg on day 2 and 400 mg on days 3 to 21)
Study NCT05082493 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Berubicin Hydrochloride
Description: Berubicin will be administered as 1-hour infusions each day for 3 consecutive days followed by 18 days off drug (ie, 21-day cycles). The starting dose is based on population PK modeling of data from adult studies and will be 1.20 mg/m2 (Dose Level 1). During the study, PK data will be incorporated into a PK model on an ongoing basis and may be used to inform dose escalation decisions
Study NCT05383495 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Intranasal dexmedetomidine 3 mcg/kg \[100 mcg/mL (max 200 mcg or 2 mL)
Study NCT05383495 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam Nasal Spray
Description: Intranasal midazolam 0.4 mg/kg \[5 mg/mL (max 10 mg or 2 mL)
Study NCT05383495 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitrous oxide
Description: 50% nitrous oxide in 50% oxygen by face mask
Study NCT06109064 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decetabine
Description: Patients will be treated with Decetabine (20mg/m\^2/d on days 1 to 5) or Azacitidine (75mg/m\^2/d on days 1 to 7)
Study NCT06109064 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Patients will be treated with Decetabine (20mg/m\^2/d on days 1 to 5) or Azacitidine (75mg/m\^2/d on days 1 to 7)
Study NCT06138769 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: Lenvatinib 12 mg (body weight 60 kg or greater) or 8 mg (body weight \< 60 kg) once orally every day
Study NCT06457867 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: microfragmented adipose tissue loaded on bovine graft
Description: microfragmented adipose tissue loaded on bovine graft on ridge preservation
Study NCT06457867 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: microfragmented adipose tissue loaded on bovine graft
Description: microfragmented adipose tissue loaded on bovine graft on ridge preservation
Study NCT05575362 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group A
Description: Group A will receive Epleys maneuver and Cawthorne Cooksey exercise for two weeks.
Study NCT05575362 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group B
Description: Group B will receive Half Somersault maneuver along with Cawthorne Cooksey exercise for two weeks.
Study NCT06529913 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Collection of environmental, biological, and clinical data
Description: All enrolled patients/healthy volunteers will undergo:~* measurement of serum and urine concentration of metals (nickel, cobalt, chromium, palladium, molybdenum, aluminium, and copper).~* Patch test to metals.~* Within-breath analysis of oscillometry parameters.~* Measurement of serum zonulin.~* Measurement of serum levels of protein oxidation products.
Study NCT06278766 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABBV-552
Description: Oral Solution
Study NCT04644211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Description: Pill taken by mouth.
Study NCT05142683 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment As Usual
Description: Various typical interventions for adolescents with depression.
Study NCT05142683 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CARIBOU-2
Description: Integrated Care Pathway intervention for adolescents with depression.
Study NCT06244888 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention Targeting Stress and Emotion Regulation
Description: This intervention involves learning and practicing relaxation exercises and setting aside time for pleasurable activities.
Study NCT06244888 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention Targeting Motivation and Self-efficacy for Weight Management
Description: This intervention involves identifying values related to weight, lifestyle, and health; identifying barriers to value-consistent living; exploring the consequences of letting barriers drive behavior; and 4) setting goals that are small, specific, attainable, and values-consistent.
Study NCT06244888 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention for Normalization of Eating
Description: This intervention involves dietary self-monitoring with the goal of staying within a calorie goal ranging from 1,200 kcal/day to 1,800 kcal/day. Participants are also provided with meal planning tools and encouraged to addresses hunger and cravings by promoting feelings of satiety via consumption of foods that are high in volume but low in calories.
Study NCT06244888 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention Targeting Physical Activity and Sleep
Description: This simple intervention prompts participants at the start of the day to schedule up to 30 minutes of moderate-to-vigorous intensity physical activity; brisk walking is encouraged. Participants also set a bedtime and wake time and are encouraged to set a reminder alarm to ensure at least 8 hours of sleep.
Study NCT04698499 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Swallowing exercise from home
Description: Treatment Arm A will consist of using pen and paper to complete the exercises. This is considered standard care. Treatment Arm B will consist of using Mobili-T to complete the exercises.
Study NCT04698499 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Swallowing exercise from home
Description: Treatment Arm A will consist of using pen and paper to complete the exercises. This is considered standard care. Treatment Arm B will consist of using Mobili-T to complete the exercises.
Study NCT06493448 — intervention group
Intervention type: OTHER
Intervention: observation
Description: This is an observational study.
Study NCT05195385 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Low-dose computed tomography of the chest
Description: Baseline low dose Ct acquisition, then at 1 year and 2 years to depict suspicious lung nodules
Study NCT05169866 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nifekalant
Description: Patients identified with new-onset atrial fibrillation with a sustained duration of greater than 1 minutes and less than 48 hours will be considered for the study. Patients randomized to nifekalant arm will receive a bolus of 0.3mg/kg IV in the first 5 minutes and a maintenance dose of 0.2-0.4mg/kg/h for 24 hours.